Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...

Breast cancer (BC) is a malignant tumor that has the highest morbidity and mortality rates in the female population, and its high tendency to metastasize is the main cause of poor clinical prognosis.

ABSTRACT: Introduction: The objectives of this study were to determine the frequency of phyllodes tumors of the breast, to describe the epidemiological, clinical and histological characteristics of ...

ABSTRACT: Introduction: The objectives of this study were to determine the frequency of phyllodes tumors of the breast, to describe the epidemiological, clinical and histological characteristics of ...

This study examines the critical role of non-coding RNAs (ncRNAs) in regulating epithelial-mesenchymal transition (EMT) in breast cancer, a prevalent malignancy with significant metastatic potential.

Thyroid cancer is a type of cancer that starts in your thyroid gland. A gland is an organ in your body that makes a substance. Your thyroid is shaped like a small butterfly and is found inside the ...

Sometimes, cancer can come back after you've had treatment. This is what doctors call a recurrence. It's different from a new cancer. And it can show up anywhere in your body. Experts usually ...

Cysts and tumors are both types of lumps commonly found in the body. While they can be similar in appearance, you can tell apart with a few key characteristics. Cysts are typically benign and are ...

However, you may have heard some conflicting information about soy and cancer risk. You might have questions like, “Is soy healthy? Is it dangerous? And if it’s OK to eat soy foods, why do some people ...

Blue Cross Blue Shield has the best insurance for most cancer patients. Kaiser Permanente is also good, but you can only get it in eight states. Average monthly rates are for a Gold plan. Monthly rate ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts caution that more research is needed. Gavin Nielsen was 2 years old when ...